Detection of alloimmune memory cells by chemical modification of the cell surface with mitogenic oxidizing agents

Manikkam Suthanthiran, Albert L. Rubin, Abraham Novogrodsky, Kurt H. Stenzel

Research output: Contribution to journalArticle

Abstract

The mitogenic oxidizing agents, neuraminidase and galactose oxidase (NAGO), and sodium periodate (IO4 ) were used to induce the differentiation of human alloimmune memory cells. NAGO or IO4 treatment of peripheral blood mononuclear (PBM) cells obtained from 10 sensitized potential allograft recipients resulted in the induction and augmentation of cytolytic activity to a D locus-defined lymphoblastoid cell panel (B cell panel) and to a HLA-disparate peripheral blood lymphocyte cell panel (PBL cell panel). The acquisition of cytolytic activity was determined in a 4-hr51Cr release assay. Treatment of in vitro-primed PBM cells (alloimmune memory cells generated in primary long-term mixed lymphocyte cultures) obtained from normal subjects with NAGO or IO4 also resulted in the induction of specific secondary cytolytic activity. In contrast, NAGO or IO4 treatment of unprimed PBM cells from normal subjects did not result in the induction of cytolytic activity despite the extensive proliferation induced by such treatment. The strikingly similar results observed with PBM cells from sensitized patients and with in vitro-primed PBM cells suggest that in vivo- and in vitro-generated alloimmune memory cells can be detected by chemical modification of the cell surface induced by NAGO or IO4 . Furthermore, our findings indicate that alloantigen-independent activation of memory cells can be accomplished by treating the memory cells with the mitogenic oxidizing agents.

Original languageEnglish
Pages (from-to)269-274
Number of pages6
JournalTransplantation
Volume30
Issue number4
DOIs
Publication statusPublished - 1 Jan 1980
Externally publishedYes

Fingerprint

Galactose Oxidase
Oxidants
Neuraminidase
Blood Cells
Lymphocytes
Isoantigens
Therapeutics
Allografts
B-Lymphocytes
In Vitro Techniques

ASJC Scopus subject areas

  • Transplantation

Cite this

Detection of alloimmune memory cells by chemical modification of the cell surface with mitogenic oxidizing agents. / Suthanthiran, Manikkam; Rubin, Albert L.; Novogrodsky, Abraham; Stenzel, Kurt H.

In: Transplantation, Vol. 30, No. 4, 01.01.1980, p. 269-274.

Research output: Contribution to journalArticle

Suthanthiran, Manikkam ; Rubin, Albert L. ; Novogrodsky, Abraham ; Stenzel, Kurt H. / Detection of alloimmune memory cells by chemical modification of the cell surface with mitogenic oxidizing agents. In: Transplantation. 1980 ; Vol. 30, No. 4. pp. 269-274.
@article{2565cfa517f149d685f929070b8e1b68,
title = "Detection of alloimmune memory cells by chemical modification of the cell surface with mitogenic oxidizing agents",
abstract = "The mitogenic oxidizing agents, neuraminidase and galactose oxidase (NAGO), and sodium periodate (IO4 −) were used to induce the differentiation of human alloimmune memory cells. NAGO or IO4 − treatment of peripheral blood mononuclear (PBM) cells obtained from 10 sensitized potential allograft recipients resulted in the induction and augmentation of cytolytic activity to a D locus-defined lymphoblastoid cell panel (B cell panel) and to a HLA-disparate peripheral blood lymphocyte cell panel (PBL cell panel). The acquisition of cytolytic activity was determined in a 4-hr51Cr release assay. Treatment of in vitro-primed PBM cells (alloimmune memory cells generated in primary long-term mixed lymphocyte cultures) obtained from normal subjects with NAGO or IO4 − also resulted in the induction of specific secondary cytolytic activity. In contrast, NAGO or IO4 − treatment of unprimed PBM cells from normal subjects did not result in the induction of cytolytic activity despite the extensive proliferation induced by such treatment. The strikingly similar results observed with PBM cells from sensitized patients and with in vitro-primed PBM cells suggest that in vivo- and in vitro-generated alloimmune memory cells can be detected by chemical modification of the cell surface induced by NAGO or IO4 −. Furthermore, our findings indicate that alloantigen-independent activation of memory cells can be accomplished by treating the memory cells with the mitogenic oxidizing agents.",
author = "Manikkam Suthanthiran and Rubin, {Albert L.} and Abraham Novogrodsky and Stenzel, {Kurt H.}",
year = "1980",
month = "1",
day = "1",
doi = "10.1097/00007890-198010000-00006",
language = "English",
volume = "30",
pages = "269--274",
journal = "Transplantation",
issn = "0041-1337",
publisher = "Lippincott Williams and Wilkins",
number = "4",

}

TY - JOUR

T1 - Detection of alloimmune memory cells by chemical modification of the cell surface with mitogenic oxidizing agents

AU - Suthanthiran, Manikkam

AU - Rubin, Albert L.

AU - Novogrodsky, Abraham

AU - Stenzel, Kurt H.

PY - 1980/1/1

Y1 - 1980/1/1

N2 - The mitogenic oxidizing agents, neuraminidase and galactose oxidase (NAGO), and sodium periodate (IO4 −) were used to induce the differentiation of human alloimmune memory cells. NAGO or IO4 − treatment of peripheral blood mononuclear (PBM) cells obtained from 10 sensitized potential allograft recipients resulted in the induction and augmentation of cytolytic activity to a D locus-defined lymphoblastoid cell panel (B cell panel) and to a HLA-disparate peripheral blood lymphocyte cell panel (PBL cell panel). The acquisition of cytolytic activity was determined in a 4-hr51Cr release assay. Treatment of in vitro-primed PBM cells (alloimmune memory cells generated in primary long-term mixed lymphocyte cultures) obtained from normal subjects with NAGO or IO4 − also resulted in the induction of specific secondary cytolytic activity. In contrast, NAGO or IO4 − treatment of unprimed PBM cells from normal subjects did not result in the induction of cytolytic activity despite the extensive proliferation induced by such treatment. The strikingly similar results observed with PBM cells from sensitized patients and with in vitro-primed PBM cells suggest that in vivo- and in vitro-generated alloimmune memory cells can be detected by chemical modification of the cell surface induced by NAGO or IO4 −. Furthermore, our findings indicate that alloantigen-independent activation of memory cells can be accomplished by treating the memory cells with the mitogenic oxidizing agents.

AB - The mitogenic oxidizing agents, neuraminidase and galactose oxidase (NAGO), and sodium periodate (IO4 −) were used to induce the differentiation of human alloimmune memory cells. NAGO or IO4 − treatment of peripheral blood mononuclear (PBM) cells obtained from 10 sensitized potential allograft recipients resulted in the induction and augmentation of cytolytic activity to a D locus-defined lymphoblastoid cell panel (B cell panel) and to a HLA-disparate peripheral blood lymphocyte cell panel (PBL cell panel). The acquisition of cytolytic activity was determined in a 4-hr51Cr release assay. Treatment of in vitro-primed PBM cells (alloimmune memory cells generated in primary long-term mixed lymphocyte cultures) obtained from normal subjects with NAGO or IO4 − also resulted in the induction of specific secondary cytolytic activity. In contrast, NAGO or IO4 − treatment of unprimed PBM cells from normal subjects did not result in the induction of cytolytic activity despite the extensive proliferation induced by such treatment. The strikingly similar results observed with PBM cells from sensitized patients and with in vitro-primed PBM cells suggest that in vivo- and in vitro-generated alloimmune memory cells can be detected by chemical modification of the cell surface induced by NAGO or IO4 −. Furthermore, our findings indicate that alloantigen-independent activation of memory cells can be accomplished by treating the memory cells with the mitogenic oxidizing agents.

UR - http://www.scopus.com/inward/record.url?scp=0018946041&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0018946041&partnerID=8YFLogxK

U2 - 10.1097/00007890-198010000-00006

DO - 10.1097/00007890-198010000-00006

M3 - Article

VL - 30

SP - 269

EP - 274

JO - Transplantation

JF - Transplantation

SN - 0041-1337

IS - 4

ER -